Gilead Sciences, Inc. (GILD) Successfully Completes Tender Offer for Shares of CV Therapeutics, Inc. (CVTX) With Over 88 Percent of Shares Tendered
4/15/2009 9:15:12 AM
More...
|
CV Therapeutics, Inc. (CVTX)'s Board of Directors Recommends Stockholders Accept Gilead Sciences Ltd. (GILD)'s $20.00 per Share Cash Tender Offer
3/19/2009 11:06:37 AM
More...
|
CV Therapeutics, Inc. (CVTX) Announces Presentations at the American College of Cardiology 58th Annual Scientific Session
3/17/2009 12:50:27 PM
More...
|
Astellas Pharma Inc. (JOBS) Pulls Plug on $1 Billion CV Therapeutics, Inc. (CVTX) (JOBS) Bid
3/16/2009 7:33:14 AM
More...
|
CV Therapeutics, Inc. (CVTX)'s (JOBS) Board of Directors Rejects Astellas Pharma Inc.'s (JOBS) Tender Offer
3/13/2009 7:30:50 AM
More...
|
Gilead Sciences, Inc. (GILD) Buying CV Therapeutics, Inc. (CVTX) for $1.4 Billion
3/12/2009 7:25:47 AM
More...
|
Astellas Pharma US, Inc. to Nominate Two Directors and Submit Proposal to Remove Remaining Four Directors of CV Therapeutics, Inc. (CVTX)
3/6/2009 8:43:23 AM
More...
|
CV Therapeutics, Inc. (CVTX) Reports Phase 1 Data Showing Proof of Concept for CVT-3619, a Novel Potential Treatment for Cardiometabolic Diseases
3/5/2009 11:01:21 AM
More...
|
CV Therapeutics, Inc. (CVTX)'s Ranexa(R) Now Available in United Kingdom and Germany
3/3/2009 11:41:14 AM
More...
|
CV Therapeutics, Inc. (CVTX) Advises Stockholders to Take No Action at This Time in Response to Astellas Pharma Inc.' Tender Offer
3/2/2009 8:59:43 AM
More...
|
|